Concepedia

Umar Raza

UR

Statistics

Publications

11

Citations

932

H-Index

11

Active since

2016

Affiliations

Bilkent University(Current)

Hacettepe University

National University of Medical Sciences

McGill University

Heidelberg University

Umar Raza is an author at Bilkent University specializing in oncology, medicine, and cancer cell signaling.

ORCID

Publications per year

2016–2022

11

Publications

11

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Özge Saatci, Aysegül Kaymak, Umar Raza et al. · Nature Communications · 2020 · 364 citations · Full text

, , +17

Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells

Annemarie Schwab, Aarif Siddiqui, Maria Eleni Vazakidou et al. · Cancer Research · 2018 · 132 citations · Full text

, , +17

Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer

Özge Saatci, Simone Borgoni, Özge Akbulut et al. · Oncogene · 2018 · 81 citations · Full text

, , +15

miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer

Merve Mutlu, Özge Saatci, Suhail A. Ansari et al. · Scientific Reports · 2016 · 74 citations · Full text

, , +17

Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer

Rasmi R. Mishra, Nevin Belder, Suhail A. Ansari et al. · Clinical Cancer Research · 2018 · 66 citations · Full text

, , +16

1–5 of 11